Concord Medical Services Holdings (CCM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Concord Medical Services Holdings (CCM) has a cash flow conversion efficiency ratio of 0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.03 Million) by net assets ($2.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CCM equity financing ratio to measure how much of total assets are equity-financed.
Concord Medical Services Holdings - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Concord Medical Services Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Concord Medical Services Holdings cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Concord Medical Services Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Concord Medical Services Holdings ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ES Australia Israel Holdings Ltd
TA:AUIS
|
-0.084x |
|
EcoBio Holdings Co. Ltd
KQ:038870
|
0.027x |
|
Nosa Med AB
ST:NOSA
|
-0.043x |
|
Greencore Group
LSE:GNC
|
0.221x |
|
Energys Group Limited Ordinary Shares
NASDAQ:ENGS
|
N/A |
|
Argenica Therapeutics Ltd
AU:AGN
|
-1.602x |
|
Samyoung S&C Co. Ltd.
KQ:361670
|
-0.051x |
|
CNPLUS Co. Ltd.
KQ:115530
|
0.851x |
Annual Cash Flow Conversion Efficiency for Concord Medical Services Holdings (2007–2025)
The table below shows the annual cash flow conversion efficiency of Concord Medical Services Holdings from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Concord Medical Services Holdings (CCM) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.85 Billion | $-201.82 Million | -0.109x | +55.63% |
| 2024-12-31 | $1.62 Billion | $-397.75 Million | -0.246x | -55.36% |
| 2023-12-31 | $1.75 Billion | $-276.47 Million | -0.158x | -47.21% |
| 2022-12-31 | $2.02 Billion | $-216.69 Million | -0.108x | +17.91% |
| 2021-12-31 | $2.74 Billion | $-359.31 Million | -0.131x | -36.84% |
| 2020-12-31 | $2.40 Billion | $-229.77 Million | -0.096x | +7.44% |
| 2019-12-31 | $1.89 Billion | $-195.35 Million | -0.103x | -509.26% |
| 2018-12-31 | $2.27 Billion | $-38.59 Million | -0.017x | -164.43% |
| 2017-12-31 | $1.01 Billion | $26.73 Million | 0.026x | +141.55% |
| 2016-12-31 | $1.23 Billion | $-78.08 Million | -0.063x | +48.11% |
| 2015-12-31 | $1.43 Billion | $-175.14 Million | -0.122x | -144.84% |
| 2014-12-31 | $1.80 Billion | $490.38 Million | 0.272x | +156.21% |
| 2013-12-31 | $2.44 Billion | $259.03 Million | 0.106x | -4.05% |
| 2012-12-31 | $2.34 Billion | $259.51 Million | 0.111x | +64.74% |
| 2011-12-31 | $2.04 Billion | $137.10 Million | 0.067x | -18.92% |
| 2010-12-31 | $2.30 Billion | $190.97 Million | 0.083x | +31.50% |
| 2009-12-31 | $2.15 Billion | $135.88 Million | 0.063x | -23.79% |
| 2008-12-31 | $565.02 Million | $46.77 Million | 0.083x | -35.52% |
| 2007-12-31 | $54.13 Million | $6.95 Million | 0.128x | -- |
About Concord Medical Services Holdings
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other tre… Read more